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HUMAN MUCOCUTANEOUS LEISHMANIASIS IN TRÊS 
BRAÇOS, BAHIA -  BRAZIL. AN AREA OF LEISHMANIA 
BRAZILIENSIS BRAZILIENSIS TRANSMISSION.
II. CUTANEOUS DISEASE. PRESENTATION AND EVOLUTION
Elmer A. Llanos-Cuentas1, Philip D. Marsden1, Edinaldo L. Lago2,
Air C. Barreto1, César C. Cuba1 and Warren D. Johnson3
The clinicai records o fl8 2 p a tien ts  with cutaneous leishmaniasisprobably due to 
Leishmania braziliensis braziliensis are analysed. 68%  had a single lesion which was 
usually an ulceron the lower anterior tibial third. M any had short histories ofone to two 
months and ali age groups were represented 13%  had closed lesions o f  a verrucose or 
plaque like nature.
Evolution o f  these skin lesions after treatment was related to the regularity o f  
antimony therapy. Although healing usually occurred in three months, the time to scarring 
after commencing treatment was variable and related to the size ofthe lesion (p  <  0.01).
Usually i f  sufficient antimony treatment was given the lesion closed.
Seven o f  the ten patients with initially negative leishmanin skin tests converted to 
positive after treatment. A significant decline o f  indirect fluorescent antibody titres 
occurred in patients followed, during and after therapy.
Key words: Cutaneous leishmaniasis. Leishmania braziliensis braziliensis.
Clinicai presentation. Evolution. Treatment.
Here we describe our findings in a total of 182 
patients with cutaneous leishmaniasis observed and 
followed in our field clinic at Três Braços, Bahia, 
Brazil, from 1976 to 1982.
MATERIAL A N D  METHODS
Diagnostic criteria and methods of parasite 
detection have already been described in the first paper 
of this series^. Apart from a clinicai diagnosis and 
compatible histology the great majority of patients had 
a positive Montenegro reaction (93%). In the analysis 
a simple classification into single or multiple cutaneous 
lesions is used.
Assessment of cure was based on clinicai exa- 
mination and a decline in the leveis of antibodies 
detected by immunofluorescence, when these were 
present Clinicai healing was defined as total 
scarring of the initial lesions without induration or 
satellite nodules and without the appearance of other 
lesions at least six months and usually a year after the 
end of treatment, depending on follow up.
We attempted to examine indirect immunofluo- 
rescent antibody in patients at intervals after healing.
New knowledge of the taxonomy of American 
human Leishmania11 and new techniques for identi- 
fication of infecting species implies further clinicai 
studies. Up to the present such studies have lacked the 
necessary technology to precisely identify the causa- 
tive organism. The many reviews of clinicai presenta­
tion rely on impressions of howL. braziliensis brazi­
liensis (Lbb) behaves in man rather than in facts17 20. 
Furthermore, since such clinicai studies are usually 
based on short term observations of hospitalised 
patients, without adequate follow up, they have limited 
value.
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7or many patients due to the terrain and difficulty of 
iccess in the rains this was not possible.
Recommended treatment since 1978 has con- 
sisted of three courses of glucantime, each course 
delivering 1 gram/kg body weight of drug in each series. 
This implies a daily dose of 28 mg/kg body weight of 
pentavalent antimony. This dose is based on our 
hospital e x p e r i e n c e 2 2 .  The Brazilian Ministry of 
Health provides the drug without cost
The majority of injections have to be given 
intramuscularly since they cannot be given under 
medicai supervision. Inspite of extensive checking in 
some patients we cannot be sure whether the full dose 
was taken. These have been classified as irregular (IR) 
when both individual dose and series was intermittent,
partially regular (PR) where the interval between 
series was more than one month, and regular (R) when 
at least two series in the manner prescribed were 
completed.
When failure occurred, patients were offered 
hospital treatment either with further antimony or 
amphotericin B. Before 1978 glucantime was not 
available and nifurtimox was used. Dosage schedules 
for this drug have been published elsewhere^ I5.
It was possible to follow up 146 patients with 
cutaneous disease for a minimum of six months and a 
maximum of 80 months. Mean follow up time was 24 
±  18 months. 89% were followed for more than one 
year, 43% for two years and 7% for more than 5 years.





Single Lesion Multiple Lesions
N p % N p % Np %
< 9 18 14.5 19 32.7 37 20.3
1 0 -1 9 54 43.5 18 31.0 72 39.6
2 0 - 2 9 14 11.3 4 6.9 IS 9.9
3 0 - 3 9 8 6.5 5 8.6 13 7.2
4 0 - 4 9 14 11.3 7 12.2 21 11.6
5 0 - 5 9 12 9.7 2 3.4 14 7.6
> 6 0 4 3.2 3 5.2 7 3.8
Total 124 100.0 58 100.0 182 100.0
RESULTS 
Clinicai presentation
The distribution of active lesions in patients 
related to age and number of lesions is given in Table 1. 
60% of patients were under 20 years of age and the 
disease was uncommon under the age of five. The 
youngest patient affected was 18 months old and the 
oldest 73 years of age. Patients under 10 years of age 
had multiple lesions more frequently (p <  0.01). 
Government survey data gives the male/female ratio 
for the area as 48/52Í0. The sex ratio of disease 
namely 57/43 was not significantly different
Duration of the disease in relation to single and 
multiple skin lesions is shown in Table 2. In 50% of 
patients this was two months or less and in 71% four 
months or less. More single lesions were noted in the 
first month of the disease (p <  0.05) but otherwise
evolution times were similar for single or multiple 
lesions. Of the 182 patients 68% had a single lesions, 
15% two lesions, and 17% three or more lesions. One 
patient had 56 lesions of only two months duration. 
Most of the multiple lesions were localised on 
the same body segment or on adjacent segments. In 
83% of patients the lesions were on the limbs. The 
commonest area was the lower anterior tibial third.
The morphology of the lesions was remarkably 
uniform 87% presenting with open ulcers on first 
consultation. Usually these ulcers had a raised 
indurated erythematous border. Early closed skin 
granulomas were only seen in multiple lesions where 
still ulceration was the main feature. Closed lesions 
were of two types -  either a warty verrucose lesion with 
hyperkeratosis histologically (8.5%) or a rarer multi­
ple plaque like, nodular infiltrative lesion (4,5%). We 
have isolated Lbb from both these types of lesions^ 
(Figure 1).
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Table 2 -  A n a ly s is  o f  182  p a tie n ts  w ith  c u ta n eo u s  le ish m a n ia s is  a s  regards d u ra tio n  o f  d isea se  a n d  n u m b e r
o f  les io n s
D ura tion  o f  
D isease
N u m b e r  o f  les io n s
T o ta lS in g le  les io n M u ltip le  le s io n s
y i f t i s f  11 f l ò J
N.° % N p % N p %
<  1 39 31.5 9 15.6 48 26.4
2 27 21.8 16 27.6 43 23.6
3 - 4 21 16.9 17 29.3 38 20.9
5 - 6 19 15.3 6 10.3 25 13.7
7 - 1 2 6 4.8 6 10.3 12 6.6
>  13 12 9.7 4 6.9 16 8.8
Total 124 100.0 58 100.0 182 100.0
Fig. 1 Morphological characteristics o f skin lesions from which Leishm ania braziliensis braziliensis was isolated.
A. Typical leishmanial ulcer (4cms) on the lower tibial third C. Plaque like infiltrative lesion of 24 months duration.
of six weeks duration. Cure with glucantime (LTB 178). 
B. Nodular infiltrative lesion of the wrist of six months 
duration. Cure with glucantime (LTB 263).
Failed to respond to pentavalent antimonial (LTB 133). 
D. Verrucose multiple lesions of 24 months duration. Cured 
with pentavalent antimonial (LTB 206).
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Table 3 shows that a relationship exists between 
the size of the skin lesion (measured by its greatest 
diameter in cm) and the evolution time. It is possible to 
find patients with ulcers of 4cm and only a 1-2 
month history. The diameter of the lesions grows 
rapidly in the first two months. Lesions of more than 
six months duration were significantly larger than the 
others (p <  0.01).
Table 3 -  Comparison o f  146 patient as regards the 
duration o f  disease and theirsize a t time o f  
initial consultation.
Duration o f  
d isea se  
(months)
N um ber o f  
patients
S ize  o f  lesion 












3 - 4 20 3.18 ±  1.21
4 - 5 23 3.35+1.44
>  6 32 4 .46+2.92
Total 146
N.S. =  Not significant 
(a) Student's t test
Evolution
In a group of 77 patients where their treatment 
was closely supervised only 35 (45%) took the two 
courses of glucantime in the prescribed manner (R). 
These patient healed in 3.25 ±  2.51 months (mean 
±  1 s.d). This is a significantly shorter healing time 
(p <  0.01) than those PR patients in whom there was a 
long delay between series (4.76 ±  2.51 months) or 
the IR patients who only took their glucantime 
irregularly (9.72 ±  5.21 months).
Figure 2 shows graphically that most patients 
whose lesions remained active used the drug irregu­
larly. Although we always recommended three series 
due the danger of metastasis in actual fact only 18% 
took this advice. Eighteen percent of patients accepted 
only one series, 45% two series and 13% four or more 
series. Invariably the incentive to continue therapy 
was when the lesion failed to heal rather than any 
medicai advice. Regular therapy during the series (PR) 
was sufficient for healing in the great majority of cases 
if only one or two series were given although it had to 
be prolonged to three treatment series in five cases and 
four in two cases to achieve this result. The senior
Number 
o f  p a t ie n ts
I
PR IR  
1 se r i  es
R PR IR  
2 s e r ie s
R PR IR 
3 s e r ie s
R PR IR 
4 s e r ie s
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NIJÍBER OF SER IES  OF GLUCANTIME
R = Regu la r d a i ly  treatm ent w ith  le s s  than one month between s e r ie s  
PR = Regu la r d a i1y treatm ent but more than one month between s e r ie s  
IR  = Ir r e n u la r  treatm ent both in  d a i ly  dose and tim es between s e r ie s
Figure 2 -  Distribution of 77 patients with cutaneous 
leishmaniasis as regards treatm ent with glucantime.
Llanos-Cuentas EA, M arsden PD, Lago EL, Barreto AC, Cuba CC, Johnson WD. H um an mucocutaneous leishmaniasis in
Três Braços, Bahia -  Brazil. A n  area o f  Leishmania braziliensis braziliensis transmission. II. Cutaneous disease.
Presentation and  evolution. Revista da Sociedade Brasileira de M edicina Tropical 17:169-177, Out-Dez, 1984
author personally observed healing in 66 patients 
(Table 4). As mightbe expected smaller lesions healed 
quicker (p <  0.01). This holds good if patients with 
irregular treatment are excluded.
Lesions on the head, trunk and arms tended to 
heal quicker although this did not reach statistical 
significance (p =  0.07). The following factors did not 
influence healing: age of the patient, sex, duration of 
disease, number of lesions and histology.
Sixteen (11%) of 146 patients in whom follow 
up was possible either failed to close their initial 
lesions (9) or relapsed (7). Only six had received 
glucantime treatment and in ali cases this drug was 
taken irregularly. The other patients had been treated 
with oral drugs such as nifurtimox or allopurinol. One 
patient (LTB 216) after regular glucantime treatment 
has continued with an open ulcer for 21 months. In 
another patient with nipple leishmaniasis after five 
series of glucantime without success the nipple was 
excised (LTB 250). Both had positive leishmanin skin 
tests. Six of the seven patients who had skin relapses 
did so in the original scar usually within a year of initial 
healing. The four patients who developed mucosal 
lesions are discussed in the third paper in this series.
Table 4 -  Relation between o f  extension o f  lesion 
(area) and scarring time in 66 patients 
with cutaneous leishmaniasis
Area o f  N.° o f  Time o f  scarring(a)  p  Value (b)
lesion (cm?) patients (m ean  ±  1 SD ) months







Excluding patients with irregular treatment: 
<  4 9 1.96+0.95
>  4 23 3.69±2.78
< 0.01
(a) Time in months from start of treatm ent to healing.
(b) Single Student’s t test.
Ten of 12 patients with a negative Montenegro 
reaction recorded in Table 1 of the paper on diagnosis5 
had the leishmanin skin test repeated after treatment 
and in 7 the reaction become positive. The three 
negative patients (in two parasites were isolated) were 
still negative one year later and two had healed their 
skin lesions. In one patient (LTB 179) despite 
adequate treatment lesion activity persisted for 15 
months before scarring and five series of glucantime 
were needed. Ali were well nourished.
Table 5 -  Evolution o f  titres o f  indirect immunofluorescent (IgG) antibody in 36 patients with cutaneous 





Titres o f  IFA - IgG % with positive 
titres MGT* p  Value(a)
< 2 0 20 40 80 160 320 640
Pre treatment 36 2 4 10 9 8 3 — 94.5 65.93 > 0 .5 0
During treatment 36 4 4 7 7 10 4 — 83.9 67.27 <0 .001
Termination 36 11 6 3 7 7 1 1 69.5 41.18 <0 .001
Scarring 36 12 10 6 2 5 1 — 66.5 27.74 <0.001
3-6 months after scarring 36 21 7 7 1 — — — 41.7 15.87
* M G T  =  M ean geometric titre.
(a) Unpaired student’s t test.
A group of 16 patients with an initially positive 
leishmanin skin test were followed up for 3 4 + 1 4  
months (range 18-72 months) after scarring and the 
test repeated. The difference between two readings 
was 6.4 ±  5.7 mm (confidence limits 95%: 3.56 to 
9.19) suggesting a significant diminution in cutaneous 
hypersensitivity.
Table 5 shows the serological titres in a group of 
36 patients who took two series of glucantime with 
resultant scarring. A  significant decline in titres o f the 
group as a whole occurred after this treatment Although 
only 30% had negative serology at the time of scarring
there is a significant decline in titres after treatment 
(p < 0 .0 0 1 ). Forty percent of patients 3-6 months 
after scarring had titres at a low levei.
Another group of patients had serological data 
over a two year period although numbers of late follow 
up sera are very small and sera sampling was done at 
irregular times. We observed that 3 outof 23 initially 
negative sera became positive with treatment. Two of 
them remained positive after two years. Fourteen out 
of 27 patients with initially positive sera persisted with 
circulating antibodies after a 7 to 24 month period of 
observation. We have a few patients in whom anti-
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bodies are still present after 3 or4 years. Patients using 
irregular treatment are common in this cohort.
We have observed four different pattems of titres 
rise and fali in our patients over the years in Três 
Braços. Two common ones are initial positive titres 
falling to negative with treatment and persistence of 
positive titres inspite of treatment. Rarer are persis- 
tently negative serology (which can occur in the 
presence of recoverable parasites) and rarer still 
negative turning to positive with treatment.
DISCUSSION
Patients with simultaneous cutaneous and 
mucosal disease are considered in the third p a p e r ' 6  in 
this series since mucosal disease is more important as 
treatment is more difficult.
Of our 62 stocks characterised by monoclonal 
antibody immunofluorescent or isoenzyme analysis to 
date only two have been of the Mexicana group. 
Neither of these patients are included in this analysis 
although their skin lesions (one single, one multiple) 
were not remarkably different from what we generally 
see in Três Braços. The task of identifying ali our 
stocks will take years particularly as the value of the 
various taxonomic methods is still under discussion. It 
is possible that other Mexicana infections are present 
in the cohort discussed here but they will be few based 
on our results. We have never seen a case of diffuse 
cutaneous leishmaniasis in Três Braços which has only 
been documented in Brazil with Mexicana infections.
The overall clinicai picture fits with what is often 
cited as the characteristic cutaneous lesions of L. 
braziliensis braziliensis infection2. Single, destruc- 
tive, extensive and chronic ulcerative lesions being the 
most common presentation. The predominance of 
such lesion on the lower anterior leg suggests that a low 
flying Phlebotomine vector is biting a frequently 
exposed site. It is tempting to relate the rapid ulcera- 
tion to the frequent necrosis found on histology^ 21 
Ridley21 is of the opinion that this necrosis is due to the 
presence of the parasite. This type of response could be 
the mechanism of destruction of the parasite and the 
surrounding tissues. Why verrucose or plaque like 
lesions occur in some patient from whom we recover 
Lbb is not clear although these lesions are usually of 
long duration2® (Figurei).
There is some indication of early lymphatic 
spread in our cases2. Multiple lesions are rarer in the 
first month of the disease and commoner in children.
We have rarely detected indurated lymphatic around 
the site of the lesion or marked local lymphadenopathy 
but these are crude measures. We have recovered 
parasites in individual cases from both these sites. 
Clinically the size and duration of multiple lesions may 
be a guide as to whether multiple infected sandfly bites 
are responsible. For instance, in our patient with 56 
lesions of two month duration two localised near the 
upper thoracic vertebral appeared in the first month 
and were larger than the other 54 lesions some of which 
were of pimple size. The conclusion was haematogenous 
spread. To date in this and other patients with evidence 
of blood stream dissemination we have not detected 
circulating parasites by inoculating peripheral blood 
into hamster or concentrating white cells and seeding 
culture and hamsters. How frequently and when 
metastasis occur awaits clarification using more 
sensitive techniques for isolating Lbb than those 
currently available.
Another aspect of multiple lesions is that they do 
not always follow local lymphatic drainage unlike 
Leishmania braziliensisguyanensis^2 but can appear 
in widely disseminated sites (12% of our patients). 
There is no sure way of telling if this is due to multiple 
infected bites or rapid blood stream dissemination. 
The sporotrichoid picture of ulcers following lymphatic 
drainage we have only seen in three patients.
That single early closed skin granulomas were 
not seen is due probably to a patient factor since they 
only seek treatment when an ulcer is established. Such 
early lesions must occur, since we see them in multiple 
lesion infections.
A  high incidence in patients under 20 years of 
age might suggest a high risk of transmission. However 
58.6% of the general population in our unpublished 
field survey were in this age group and disease 
expression appears to reflect the age distribution in our 
population. Does the occurrence of leishmaniasis in 
children and occasionally in house bound women who 
claim no contact with the cacao farms indicate 
peridomiciliary transmission? We still know so little 
about the epidemiology of the transmission of leish­
maniasis in Três Braços that this remains a speculative 
question. Despite much field activity we have still to 
incriminate the suspected vector (Lutzomyia whitmani) 
or find an infected animal with Lbb apart from the 
domestic dog3.
The application of glucantime under field condi- 
tions is a persistent problem even in supervised 
programmes. Its efficacy cannot be doubted. In this
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large series we have had no absolute failure, but its 
application in patients living in remote rural areas 
requires great effort. We have provided glass syringes, 
taught sterilisation procedures and attempted to install 
a network of people who can give an intramuscular 
injection in such areas. For a sixty kilo man to accept 
20ml of drug intramuscularly daily for ten days is 
painful. With children such injection regimes can be even 
more difficult It is not suprising that patients often 
abandon treatment when they see a response. In our 
clinic we give glucantime by slow intravenous injection 
(no diluentis necessary). We ask ali patients to restfor 
30 minutes before walking home. We are fortunate to 
have had no serious side effects in the area.
The main conclusion of our detailed analysis of such 
therapy is that if injections are taken as prescribed the 
response in terms of clinicai healing is good enough in 
cutaneous disease to use only two treatment series. A 
distinct possibility exists that in the future we could 
given continuous therapy for 20 days at a dose of 20mg 
Sbv/kilo per day2. However as demonstrated by our 
brief descriptions of some of our patients in the results 
section, the response to therapy is variable and some 
patients only respond to much more antimony therapy 
than is normal.
Our data also show that irregular therapy with 
glucantime increases significantly (p <  0.01) the risk 
of relapse, of scarring time and the possibility of 
therapeutic failure. Also that our decision to abandon 
nifurtimox alone or nifurtimox plus glucantime given 
in one series is justified since the majority of relapses 
have occurred in this group. With no altemative drug in 
sight we must concentrate on more efficient glucantime 
schedules for field use.
That larger lesions are slower to heal comes as 
no suprise. As we observed elsewhere13 it is unfor- 
tunate that so many lesions are on the lower anterior 
leg since this is a site of poor vascularisation with 
impaired healing power.
In the first paper in this series we showed that 
92% of patients had a positive leishmanin skin test5 
when first seen. Although the majority of those patients 
with negative delayed skin hypersensitivity converted 
after treatment, of the three patients with persistently 
negative skin test two healed. Although various factors 
such as parasite load, nutritional state etc. may 
interfere with this skin test1 none of them could be 
implicated in these patients.
It is thought by some that the leishmanin skin 
tests remains positive throughout life permitting a 
retrospective diagnosis of infection in 100% of 
cases7 20. The group of 15 patients in whom we 
observed diminution of skin test reactivity after treat­
ment is too small to draw firm conclusions but our 
results suggest that changes in the leishmanin skin test 
may occur more rapidly after treatment than has been 
noted by other workers1** 19. The persistence of skin 
test positivity could indicate the presence of living 
parasites and this test might have value in the evalua- 
tion of cure. Further investigation is necessary.
Decline or disappearance of circulating antibo- 
dies is a better established criterion of cu re4 6 23 \y e 
habitually use it in our treatment evaluations both in 
the hospital22 and in the field5 and as our results show 
titres fali over time after successful treatment 
(p <  0.001). However we have a relatively large 
number of patients in whom low titres persist. We need 
further studies to assess whether such titres represent 
parasite persistence. Serology is also useful in predict- 
ing relapse. We can offer no explanation for why some 
patients, even with detectable parasites, do not 
develop detectable antibodies although using the more 
sensitive Elisa test this number is reduced.
The differential diagnosis of American cutaneous 
leishmaniasis has been discussed in detail elsewhe- 
re® 17. Três Braços patients frequently confuse 
leishmaniasis with vascular or stasis ulcer although 
these rarely present difficulties for the clinician. 
Epidermoid carcinomas of both skin and mucosa have 
been misdiagnosed before histology became available. 
Fortunately Paracoccidiodes brasiliensis is easily 
seen in biopsies. Sometimes ulcers following trauma 
(insect bites, scratching, football) can mimic leishma­
niasis especially as leishmanial ulceration can appear 
at the site of trauma. Practice in our clinic in Três 
Braços suggests that an experienced clinician will be 
righ in the diagnosis made on clinicai grounds in the 
majority of patients.
The refusal of most patient to have a further 
biopsy after healing is understandable. Cutaneous 
leishmaniasis does not carry the stigma of leprosy and 
patients know that the chances of relapses or reinfec- 
tion in Três Braços are small. In the few patients in 
whom we have attempted to isolate parasites from 
biopsies of healed lesions the results have been 
negative but we know from experimental studies .that 
parasite can persist in healed lesions11 24 We briefly 
discussed the four possible criteria of cure in this
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difficult disease some years ago15. Histological and 
parasitological cure assessment not being possible in 
view of the difficulty of biopsy we have to rely on 
clinicai and serological evidence.
SUM ÁRIO
Foram analisados os dados clínicos de 182 
pacientes com leishmaniose cutânea, provavelmente 
causada por  Leishmania braziliensis braziliensis. 
Sessenta e oito p o r cento apresentavam uma única 
lesão, usualmente uma úlcera, na terça parte inferior 
anterior da tíbia. Todos os grupos etários estavam  
representados e muitos apresentaram histórico de um 
a dois meses. Treze p o r cento apresentavam lesões 
fechadas de natureza verrucosa ou em placa.
Após tratamento, a evolução destas lesões fo i  
relacionada à regularidade da terapia por antimô- 
nio. Embora a cura usualmente ocorresse em três 
meses, o tempo de cicatrização, após o início de 
tratamento, fo i variável e relativo ao tamanho da 
lesão (p < 0 .01 ). Em geral a lesão fechava quando 
era dado suficiente antimônio como tratamento.
Sete entre dez pacientes que apresentavam teste 
cutâneo negativo para leishmania tom avam  posi­
tivos após o tratamento.
Observou-se por fluorescência indireta, um 
declínio significante nos títulos de anticorpos em 
pacientes acompanhados durante e após a terapia.
Palavras chaves: Leishmania braziliensis bra­
ziliensis. Apresentação clínica. Evolução. Trata­
mento.
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